Successful Implementation of the Single Pass KRONOS Biopsy Closure Device in Real-time Clinical Scenarios

Monday, February 19, 2024

Single Pass, the pioneer in biopsy closure cauterization devices, is thrilled to announce the successful completion of its inaugural real-world cases using its groundbreaking device. These pioneering procedures took place at the Universitario Campus Bio Medico, Fondazione Policlinico in Rome, Italy, showcasing the device's exceptional capabilities and its potential to revolutionize the field of biopsy closure.

In the first instance, a kidney biopsy was performed under CT guidance, employing the 22cm Single Pass KRONOS device in conjunction with a 13cm biopsy needle. The procedure resulted in effective cauterization and precise lesion targeting, thanks to the seamless integration of the Single Pass KRONOS probe with the biopsy needle and depth gauge.

In the second case, an 80-year-old female underwent a liver biopsy using a 17cm Single Pass KRONOS device under ultrasound guidance. Despite encountering significant post-sample removal bleeding, the device provided excellent visibility, facilitating smooth track closure and complete cauterization. Physicians lauded the device for its user-friendly design and performance under ultrasound guidance.

In both scenarios, the Single Pass KRONOS device effectively stopped post-biopsy bleeding by cauterizing the biopsy channel. The success of these initial real-life cases underscores the transformative potential of the Single Pass KRONOS biopsy closure cauterization device. With its exceptional performance and ease of use, the Single Pass KRONOS device is poised to redefine biopsy closure procedures.




Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital Congress